"Models, Economic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Statistical models of the production, distribution, and consumption of goods and services, as well as of financial considerations. For the application of statistics to the testing and quantifying of economic theories MODELS, ECONOMETRIC is available.
| Descriptor ID |
D018803
|
| MeSH Number(s) |
E05.318.740.500.600 E05.599.835.890 N05.715.360.750.530.500 N06.850.520.830.500.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Models, Economic".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Investigative Techniques [E05]
- Epidemiologic Methods [E05.318]
- Statistics as Topic [E05.318.740]
- Models, Statistical [E05.318.740.500]
- Models, Economic [E05.318.740.500.600]
- Models, Theoretical [E05.599]
- Models, Statistical [E05.599.835]
- Models, Economic [E05.599.835.890]
- Health Care [N]
- Health Care Quality, Access, and Evaluation [N05]
- Quality of Health Care [N05.715]
- Health Care Evaluation Mechanisms [N05.715.360]
- Statistics as Topic [N05.715.360.750]
- Models, Statistical [N05.715.360.750.530]
- Models, Economic [N05.715.360.750.530.500]
- Environment and Public Health [N06]
- Public Health [N06.850]
- Epidemiologic Methods [N06.850.520]
- Statistics as Topic [N06.850.520.830]
- Models, Statistical [N06.850.520.830.500]
- Models, Economic [N06.850.520.830.500.600]
Below are MeSH descriptors whose meaning is more specific than "Models, Economic".
This graph shows the total number of publications written about "Models, Economic" by people in this website by year, and whether "Models, Economic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 2 | 2 |
| 2012 | 2 | 1 | 3 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 10 | 11 |
| 2015 | 1 | 2 | 3 |
| 2016 | 2 | 2 | 4 |
| 2017 | 1 | 4 | 5 |
| 2018 | 3 | 5 | 8 |
| 2019 | 2 | 5 | 7 |
| 2020 | 3 | 2 | 5 |
| 2021 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Models, Economic" by people in Profiles.
-
Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases. Genet Med. 2022 01; 24(1):109-118.
-
Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination. J Infect Dis. 2021 09 17; 224(6):938-948.
-
Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer. Gynecol Oncol. 2021 04; 161(1):56-62.
-
Process Mapping and Activity-Based Costing of the Intravitreal Injection Procedure. Curr Eye Res. 2021 05; 46(5):694-703.
-
Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.
-
Time-Driven Activity-Based Costing to Model Cost Utility of Enhanced Recovery after Surgery Pathways in Microvascular Breast Reconstruction. J Am Coll Surg. 2020 05; 230(5):784-794.e3.
-
Systematic Review of Economic Evaluations of Cycling Versus Swapping Medications in Patients With Rheumatoid Arthritis After Failure to Respond to Tumor Necrosis Factor Inhibitors. Arthritis Care Res (Hoboken). 2020 03; 72(3):343-352.
-
Cost-effectiveness of brentuximab vedotin with chemotherapy in treatment of CD30-expressing PTCL. Am J Manag Care. 2020 02 01; 26(2):e41-e49.
-
Cost-effectiveness of a melanoma screening programme using whole disease modelling. J Med Screen. 2020 09; 27(3):157-167.
-
Trend and Economic Burden of Intravenous Narcotic Analgesic Utilization in Major Vascular Interventions in the United States. Ann Vasc Surg. 2020 Jul; 66:289-300.e2.